All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

36

Reset

36 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • IanalumabVAY736, VAY736 AIPhase 318 trials

    Novartis · Primary Immune Thrombocytopenia (ITP), Systemic Lupus Erythematosus, Sjogren Syndrome

  • AfimkibartRO7790121, RVT-3101Phase 312 trials

    Roche (Genentech) · Moderately to Severely Active Ulcerative Colitis, Moderately to Severely Active Crohns Disease, Atopic Dermatitis

  • MK-7240PRA023, TulisokibartPhase 310 trials

    Merck & Co. · Ulcerative Colitis, Psoriatic Arthritis, Crohn's Disease

  • LutikizumabABT-981Phase 38 trials

    AbbVie · Hidradenitis Suppurativa, Atopic Dermatitis, Rheumatoid Arthritis

  • TLL-018Phase 38 trials

    Hangzhou Highlightll Pharmaceutical Co., Ltd · Chronic Spontaneous Urticaria (CSU), Rheumatoid Arthritis, Chronic Spontaneous Urticaria

  • IMVT-1402Phase 37 trials

    Immunovant Sciences GmbH · Graves' Disease, Rheumatoid Arthritis, Subacute Cutaneous Lupus Erythematosus

  • FilgotinibGS-6034, GLPG0634Phase 36 trials

    Alfasigma S.p.A. · Ulcerative Colitis, Polyarticular Course Juvenile Idiopathic Arthritis, Juvenile Idiopathic Arthritis (JIA)

  • LNK01001Phase 33 trials

    Lynk Pharmaceuticals Co., Ltd · Ankylosing Spondylitis, Atopic Dermatitis, Rheumatoid Arthritis

  • Beijing VDJBio Co., LTD. · Anti IL-6R, Idiopathic Multicentric Castleman's Disease, Castleman's Disease, Multicentric

  • ABBV-722Phase 32 trials

    AbbVie · Rheumatoid Arthritis, Systemic Sclerosis

  • LevilimabPhase 31 trial

    Biocad · Rheumatoid Arthritis

  • mAbxience Research S.L. · Rheumatoid Arthritis (RA)

  • rapcabtagene autoleucelYTB323Phase 28 trials

    Novartis · Lupus Nephritis, Rheumatoid Arthritis (RA) and Sjögren's Disease (SjD), ANCA Associated Vasculitis (AAV)

  • AP1189Phase 23 trials

    SynAct Pharma Aps · Rheumatoid Arthritis (RA), Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy, Severe Proteinuria Due to Idiopathic Membranous Nephropathy

  • GenSci048Phase 23 trials

    Changchun GeneScience Pharmaceutical Co., Ltd. · Uveitis, Systemic Sclerosis Associated Interstitial Lung Disease, Rheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD)

  • QLS12010Phase 23 trials

    Qilu Pharmaceutical Co., Ltd. · Adults With Moderate-to-severe Hidradenitis Suppurativa, Moderate-to-severe Atopic Dermatitis, Rheumatoid Arthritis (RA)

  • CIT-013Phase 22 trials

    Citryll BV · Hidradenitis Suppurativa (HS), Rheumatoid Arthritis

  • CIT-013 dosePhase 22 trials

    Citryll BV · Hidradenitis Suppurativa (HS), Rheumatoid Arthritis

  • JAB-8263Phase 22 trials

    Jacobio Pharmaceuticals Co., Ltd. · Rheumatoid Arthritis (RA), NSCLC, SCLC

  • NKX019Phase 22 trials

    Nkarta, Inc. · Lupus Nephritis, Primary Membranous Nephropathy, Systemic Sclerosis

  • RosnilimabANB030Phase 22 trials

    AnaptysBio, Inc. · Rheumatoid Arthritis, Ulcerative Colitis

  • SPY002-072SPY072Phase 22 trials

    Spyre Therapeutics, Inc. · Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis

  • TollB-001Phase 22 trials

    Toll Biotech Co. Ltd. (Beijing) · Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc)

  • vilamakitugXB2001, NatrunixPhase 22 trials

    XBiotech, Inc. · Axial Spondyloarthritis, Ankylosing Spondylitis, r-axSpA

  • AZD1163Phase 21 trial

    AstraZeneca · Rheumatoid Arthritis

  • BMS-986528Phase 21 trial

    Bristol Myers Squibb · Arthritis, Rheumatoid

  • ELV001Phase 21 trial

    Elevara Medicines Limited · Active Rheumatoid Arthritis

  • FT839Phase 21 trial

    Fate Therapeutics · ANCA-Associated Vasculitis (AAV), Idiopathic Inflammatory Myositis (IIM), Rheumatoid Arthritis (RA)

  • GenSci120Phase 21 trial

    Changchun GeneScience Pharmaceutical Co., Ltd. · Rheumatoid Arthritis

  • LY3871801Phase 21 trial

    Eli Lilly · Rheumatoid Arthritis

  • PF-08154225Phase 21 trial

    Pfizer · Systemic Lupus Erythematosus, Rheumatoid Arthritis, Idiopathic Inflammatory Myositis

  • PTC844Phase 21 trial

    PTC Therapeutics · Rheumatoid Arthritis

  • QEL-005Phase 21 trial

    Quell Therapeutics Limited · Diffuse Cutaneous Systemic Sclerosis, Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc)

  • RavagalimabPhase 21 trial

    AbbVie · Rheumatoid Arthritis

  • SAR441566Phase 21 trial

    Sanofi · Rheumatoid Arthritis

  • SHR-3045Phase 21 trial

    Guangdong Hengrui Pharmaceutical Co., Ltd · Moderate to Severe Active Rheumatoid Arthritis

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.